Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)
|
0.630 -0.010 (-1.56%) 3:04EST Delayed |
|
|
|
- Compare ANPI with:
- View: Line | Candlestick
Company Profile
Angiotech Pharmaceuticals, Inc.
1618 Station Street
Vancouver, BC V6A 1B6
Canada - Map
Phone: (604) 221-7676
Fax: (604) 221-2330
Website: www.angiotech.com
CEO: Dr. William L. Hunter,M.D.,M.Sc.
Employees: 1,350
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A pharmaceutical and medical device company
A pharmaceutical and medical device company that discovers, develops and markets innovative technologies focused on acute and surgical applications.
Recent news for ANPI
-
Zacks - Jul 12 at 8:14AM (EST)
-
Zacks - Jul 09 at 3:47PM (EST)
-
EDGAR Online - Jul 08 at 1:23PM (EST)
-
PR Newswire - Jul 08 at 1:00PM (EST)
-
Angiotech Pharmaceuticals Earnings Call scheduled for Fri, July 30
CCBN - Jul 01 at 12:15PM (EST)
-
Angiotech Pharmaceuticals Announces Conference Call and Webcast
PR Newswire - Jun 24 at 1:00PM (EST)
-
Briefing.com - Jun 11 at 1:01PM (EST)
-
PR Newswire - Jun 11 at 1:00PM (EST)
-
PR Newswire - Jun 10 at 6:30PM (EST)
-
Briefing.com - Jun 10 at 2:03PM (EST)
Member sentiment (?) Neutral
Recent opinions on ANPI
-
FDA Clinical Pipeline Updates: ANPI, AMGN, AGAM, GPRO
Jun 09 at 2:00PM (EST) (By StocksHaven)
No members own ANPI